Pathway |
Cell Line |
Activator |
Inhibitor |
ARE-bla HepG2 |
tBHQ |
Ro-31-8220 |
|
NFAT-bla RA-1 |
Goat anti-Human IgM |
Syk Inhibitor II |
|
CRE-bla HEK 293T |
Forskolin |
H-89 |
|
CRE-bla Jurkat |
Forskolin |
H-89 |
|
p53RE-bla HCT-116 |
Mitomycin |
N/A |
|
ESRE-bla HeLa |
Tunicamycin |
N/A |
|
MMTV-bla HeLa |
Dexamethasone |
RU-486 |
|
HSE-bla HeLa |
17-AAG |
Quercetin |
|
HRE-bla ME-180 |
CoCl2 |
Chetomin |
|
STAT6-bla RA1 |
IL-4 |
JAK Inhibitor I |
|
irf1-bla HEL |
N/A |
JAK Inhibitor I |
|
ISRE-bla HEK 293T |
IFN-alpha |
JAK Inhibitor 1 |
|
ISRE-bla Jurkat |
IFN-alpha |
JAK Inhibitor I |
|
SIE-bla HEK 293T |
IFN-gamma |
JAK Inhibitor I |
|
SIE-bla HEK 293T |
IL-6 |
JAK Inhibitor I |
|
SIE-bla ME-180 |
IL-6 |
JAK Inhibitor 1 |
|
SIE-bla ME-180 |
IFN-gamma |
JAK Inhibitor 1 |
|
irf1-bla TF1 |
GM-CSF |
JAK Inhibitor 1 |
|
irf1-bla TF1 |
EPO |
JAK Inhibitor I |
|
c-fos-bla HEK 293T |
PMA |
U0126 |
|
c-fos-bla ME-180 |
EGF |
PD153035 |
|
AP1-bla ME-180 |
EGF |
PD153035 |
|
AP1-bla A375 |
N/A |
Raf1 Kinase Inhibitor |
|
NFkB-bla Jurkat |
TNF-alpha |
Withaferin A |
|
NFkB-bla ME-180 |
TNF-alpha |
Withaferin A |
|
NFkB-bla ME-180 |
IL-1 beta |
Withaferin A |
|
NFkB-bla THP-1 |
TNF-alpha |
Withaferin A |
|
TREx FOXO3-DBE-bla HeLa |
Insulin |
Triciribine |
|
TrkA-NFAT-bla CHO-K1 |
NGF-2.5S |
K252a |
|
TrkB-NFAT-bla CHO-K1 |
BDNF |
K252a |
|
TrkC-NFAT-bla CHO-K1 |
Neurotrophin-3 |
K252a |
|
NFAT-bla Jurkat |
Thapsigargin |
Ro-31-8220 |
|
NFAT-bla Jurkat |
anti-CD3:CD28 |
Ro-31-8220 |
|
SBE-bla HEK 293T |
TGF-beta |
TGF-beta R1 Kinase Inhibitor |
|
AP1-bla ME-180 |
TNF-alpha |
JNK Inhibitor II |
|
NFkB-bla THP-1 |
LPS |
Withaferin A |
|
LEF/TCF-bla HCT-116 |
Wnt-3A |
ICG-001 |
|
LEF/TCF-bla SW 480 |
None |
ICG-001 |